Literature DB >> 16407297

Four and a half LIM protein 1 binds myosin-binding protein C and regulates myosin filament formation and sarcomere assembly.

Meagan J McGrath1, Denny L Cottle, Mai-Anh Nguyen, Jennifer M Dyson, Imogen D Coghill, Paul A Robinson, Melissa Holdsworth, Belinda S Cowling, Edna C Hardeman, Christina A Mitchell, Susan Brown.   

Abstract

Four and a half LIM protein 1 (FHL1/SLIM1) is highly expressed in skeletal and cardiac muscle; however, the function of FHL1 remains unknown. Yeast two-hybrid screening identified slow type skeletal myosin-binding protein C as an FHL1 binding partner. Myosin-binding protein C is the major myosin-associated protein in striated muscle that enhances the lateral association and stabilization of myosin thick filaments and regulates actomyosin interactions. The interaction between FHL1 and myosin-binding protein C was confirmed using co-immunoprecipitation of recombinant and endogenous proteins. Recombinant FHL2 and FHL3 also bound myosin-binding protein C. FHL1 impaired co-sedimentation of myosin-binding protein C with reconstituted myosin filaments, suggesting FHL1 may compete with myosin for binding to myosin-binding protein C. In intact skeletal muscle and isolated myofibrils, FHL1 localized to the I-band, M-line, and sarcolemma, co-localizing with myosin-binding protein C at the sarcolemma in intact skeletal muscle. Furthermore, in isolated myofibrils FHL1 staining at the M-line appeared to extend partially into the C-zone of the A-band, where it co-localized with myosin-binding protein C. Overexpression of FHL1 in differentiating C2C12 cells induced "sac-like" myotube formation (myosac), associated with impaired Z-line and myosin thick filament assembly. This phenotype was rescued by co-expression of myosin-binding protein C. FHL1 knockdown using RNAi resulted in impaired myosin thick filament formation associated with reduced incorporation of myosin-binding protein C into the sarcomere. This study identified FHL1 as a novel regulator of myosin-binding protein C activity and indicates a role for FHL1 in sarcomere assembly.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16407297     DOI: 10.1074/jbc.M512552200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Expression of FHL1 in gastric cancer tissue and its correlation with the invasion and metastasis of gastric cancer.

Authors:  Yuanhong Xu; Zhe Liu; Kejian Guo
Journal:  Mol Cell Biochem       Date:  2011-12-06       Impact factor: 3.396

2.  Goodpasture antigen-binding protein (GPBP) directs myofibril formation: identification of intracellular downstream effector 130-kDa GPBP-interacting protein (GIP130).

Authors:  Francisco Revert-Ros; Ernesto López-Pascual; Froilán Granero-Moltó; Jesús Macías; Richard Breyer; Roy Zent; Billy G Hudson; Anas Saadeddin; Fernando Revert; Raül Blasco; Carmen Navarro; Deborah Burks; Juan Saus
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

3.  FHL3 negatively regulates the differentiation of skeletal muscle satellite cells in chicken.

Authors:  Shunshun Han; Can Cui; Yan Wang; Haorong He; Xiaoxu Shen; Yuqi Chen; Zihao Liu; Qing Zhu; Diyan Li; Huadong Yin
Journal:  3 Biotech       Date:  2019-05-07       Impact factor: 2.406

4.  Myosin binding protein C1: a novel gene for autosomal dominant distal arthrogryposis type 1.

Authors:  Christina A Gurnett; David M Desruisseau; Kevin McCall; Ryan Choi; Zachary I Meyer; Michael Talerico; Sara E Miller; Jeong-Sun Ju; Alan Pestronk; Anne M Connolly; Todd E Druley; Conrad C Weihl; Mathew B Dobbs
Journal:  Hum Mol Genet       Date:  2010-01-02       Impact factor: 6.150

5.  Effects of mild-exercise training cessation in human skeletal muscle.

Authors:  Jonny St-Amand; Mayumi Yoshioka; Yuichiro Nishida; Takuro Tobina; Naoko Shono; Hiroaki Tanaka
Journal:  Eur J Appl Physiol       Date:  2011-06-17       Impact factor: 3.078

6.  Dysregulation of FHL1 spliceforms due to an indel mutation produces an Emery-Dreifuss muscular dystrophy plus phenotype.

Authors:  Heather R Tiffin; Zandra A Jenkins; Mary J Gray; Sophia R Cameron-Christie; Jennifer Eaton; Salim Aftimos; David Markie; Stephen P Robertson
Journal:  Neurogenetics       Date:  2013-03-02       Impact factor: 2.660

7.  Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1.

Authors:  Joachim Schessl; Ana L Taratuto; Caroline Sewry; Roberta Battini; Steven S Chin; Baijayanta Maiti; Alberto L Dubrovsky; Marcela G Erro; Graciela Espada; Monica Robertella; Maria Saccoliti; Patricia Olmos; Leslie R Bridges; Peter Standring; Ying Hu; Yaqun Zou; Kathryn J Swoboda; Mena Scavina; Hans-Hilmar Goebel; Christina A Mitchell; Kevin M Flanigan; Francesco Muntoni; Carsten G Bönnemann
Journal:  Brain       Date:  2009-01-29       Impact factor: 13.501

Review 8.  Myosin binding protein-C slow: an intricate subfamily of proteins.

Authors:  Maegen A Ackermann; Aikaterini Kontrogianni-Konstantopoulos
Journal:  J Biomed Biotechnol       Date:  2010-04-08

9.  Perfusion of veins at arterial pressure increases the expression of KLF5 and cell cycle genes in smooth muscle cells.

Authors:  Emre Amirak; Mustafa Zakkar; Paul C Evans; Paul R Kemp
Journal:  Biochem Biophys Res Commun       Date:  2009-12-02       Impact factor: 3.575

10.  Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy.

Authors:  Belinda S Cowling; Meagan J McGrath; Mai-Anh Nguyen; Denny L Cottle; Anthony J Kee; Susan Brown; Joachim Schessl; Yaqun Zou; Josephine Joya; Carsten G Bönnemann; Edna C Hardeman; Christina A Mitchell
Journal:  J Cell Biol       Date:  2008-12-15       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.